Riskpilot← Back to searchSign inGet full accessTammer BioLab Oy
OYActiveY-tunnus 0679027-7Biokatu 10Manufacture of other chemical products n.e.c. · NACE 2059Est. 1987— employeeswww.tammerbiolab.fi
Revenue 2024
EUR 1,7M
-99% vs 2023
EBITDA margin
26.9%
-99% vs 2023
Equity ratio
59.8%
Financial strength
Net profit 2024
EUR 379K
-99% vs 2023
| Revenue | EUR 1,7M | -99% |
| EBITDA | EUR 467K | -99% |
| Net profit | EUR 379K | -99% |
| Total assets | EUR 827K | -100% |
| Equity | EUR 495K | -100% |
| Employees | — | — |
Legal name
Tammer BioLab Oy
Y-tunnus number
0679027-7
Legal form
Osakeyhtiö
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
28. lokakuuta 1987
Share capital
EUR 2 523
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on laboratoriodiagnostisten laitteiden ja tarvikkeiden valmistus ja myynti, vienti ja tuonti sekä tähän liittyvien palveluiden tarjoaminen. Yhtiö voi omistaa ja hallita kiinteistöjä, osakkeita ja arvopapereita, käydä niillä kauppaa sekä harjoittaa omistamiensa tai hallitsemiensa tilojen osalta vuokraustoimintaa. Yhtiön toimialana on myös kaikki muu laillinen liiketoiminta.
Address
Biokatu 10
Phone
+3580505422210
Email
tilaukset@tammerbiolab.fi
Website
www.tammerbiolab.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 305 | 2 965 | 2 656 | 220 990 | 1 737 |
| Staff expenses | −1 183 | −1 454 | −977 | −75 807 | −699 |
| EBITDA | 328 | 502 | 1 128 | 72 291 | 467 |
| Depreciation & amort. | −72 | −80 | −49 | −5 378 | −52 |
| EBIT | 256 | 421 | 1 079 | 66 913 | 414 |
| Net financials | −8 | −4 | −18 | −51 | 38 |
| Profit before tax | 248 | 417 | 1 061 | 61 839 | 452 |
| Tax | 50 | 84 | 216 | 137 | 73 |
| Net profit | 198 | 333 | 846 | 48 097 | 379 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 001 | 1 136 | 1 827 | 222 032 | 827 |
| Equity | 432 | 724 | 1 512 | 187 200 | 495 |
| Long-term debt | 39 | 18 | — | 870 | 0 |
| Short-term debt | 530 | 393 | 315 | 33 962 | 332 |
| Total debt | 569 | 411 | 315 | 34 832 | 332 |
EBITDA margin
26.9%
This company
15.8%
Market median
+70% vs market
20202024
Equity ratio
59.8%
This company
38.2%
Market median
+57% vs market
20202024
Return on equity
76.6%
This company
18.4%
Market median
+316% vs market
20202024
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20202024
Asset turnover
2.10×
This company
1.12×
Market median
+87% vs market
20202024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TS Chief Executive Officer | Chief Executive Officer | 2018 |
JM Deputy Member | Deputy Member | 2019 |
| Former (2) | ||
MT Audit | Audit | 2019 – 2023 |
MA | Audit | 2015 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
| Former (1) | ||
| Board of Directors | 2018 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tammer BioLab Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikko Tuomas Lilja | Audit | 0 companies |
| Tuomas Sakari Jokiranta | Chief Executive Officer | 0 companies |
| Martin Andreas Grandell | Audit | 0 companies |
| Jutta Maria Jokiranta | Deputy Member | 0 companies |
| Dina Sorokina | Board of Directors | 0 companies |
| Kim-Gunnar Lang | Board of Directors | 0 companies |